Follow The Filings

CNA CNA Financial

CNA Financial earnings company data as of 4:45 AM ET 10/31

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 2 Nov EPS 1.19 — —
Rev — — —

Insider trades

Open-market buys and sales by CNA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CNA insider trades
  • None no insider bought on the open market
  • $1.8M sold by 3 insiders outside a trading plan
  • $874K sold by 1 insider under 10b5-1 plans
  1. Mark Steven James EVP, Chief Risk & Rein Off
    Sale
    $440K 8,273 shares at $53.15 24% of stake
    Traded Aug 4 Filed Aug 5
  2. Daniel Paul Franzetti EVP & CAO
    Sale
    $1.2M 22,656 shares at $53.09 25% of stake
    Traded Aug 4 Filed Aug 4
  3. Jeffrey John Neuenschwander SVP & General Counsel
    Sale
    $151K 3,287 shares at $45.97 31% of stake
    Traded Mar 19 Filed Mar 20
  4. Dino Robusto Chair
    Planned sale
    $298K 6,250 shares at $47.62 0.9% of stake
    Traded Jan 2 Filed Jan 6
  5. Dino Robusto Chair
    Planned sale
    $293K 6,250 shares at $46.92 0.9% of stake
    Traded Dec 1, 2025 Filed Dec 1, 2025
  6. Dino Robusto Chair
    Planned sale
    $283K 6,250 shares at $45.28 0.9% of stake
    Traded Nov 3, 2025 Filed Nov 3, 2025

Also filed in the last 12 months, not counted as buying or selling: 9 stock grants, 9 share withholdings for taxes, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
8-K 2.02,9.01
10-Q
8-K 2.02,9.01
10-Q
8-K 5.07
DEFA14A
DEF 14A
10-K
8-K 2.02,9.01
8-K 2.02,9.01
8-K 5.02,9.01
10-Q
8-K 8.01,9.01
8-K 1.01,9.01
424B2
424B3
8-K 2.02,9.01
10-Q
8-K 5.02

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.